Affordable same-day HPV screening and treatment in South Africa
Research Project 2
Finding ways to make same-day HPV testing and immediate treatment affordable and available for people getting cervical cancer screening in South Africa.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Columbia University Health Sciences NIH-funded |
| Lab location | 1 site (New York, United States) |
| Project ID | NIH-11146519 on NIH RePORTER |
What this research studies
This project focuses on bringing HPV-based same-day screen-and-treat (SAT) into routine public clinics in Khayelitsha, South Africa. Using a WHO costing tool, the team will compare costs of cervical cancer screening before and after introducing the Xpert HPV point-of-care SAT to calculate cost per person screened and cost per person screened and treated. They will perform time-and-motion and other implementation analyses to measure staff time, workflows, and financing needs for scaling the approach. The project builds on long-term collaboration between Columbia University and the University of Cape Town and uses linked implementation work to tailor affordable, scalable strategies.
Who could benefit from this research
Good fit: People with cervixes who seek cervical cancer screening at public primary care clinics in Khayelitsha, South Africa are the ideal candidates to take part or benefit.
Not a fit: People who do not attend the targeted clinics, who live outside the implementation area, or who are not seeking screening are unlikely to be directly helped by this project.
Why it matters
Potential benefit: If successful, this could lower the cost and increase uptake of same-day HPV screening and treatment in public clinics, helping prevent more cervical cancer deaths.
How similar studies have performed: Point-of-care HPV tests such as Xpert have shown promise and cost-effectiveness in research settings, but broad real-world roll-out of screen-and-treat is still limited.
Where this research is happening
New York, United States
- Columbia University Health Sciences — New York, United States (Active)
Researchers
- Principal investigator: Castor, Delivette — Columbia University Health Sciences
- Study coordinator: Castor, Delivette
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.